Adult Onset Nocturnal Enuresis: Identifying Causes, Cofactors and Impact on Quality of Life

Dominic Lee, Benjamin E. Dillon, Gary E. Lemack

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: The objectives of the present study were: (i) Evaluate common co-pathologies associated with, and potentially contributing to adult onset Nocturnal enuresis (NE) in a tertiary referral population; and (ii) quantify its impact on QoL with validated questionnaires. Methods: Following Institutional Review Board approval, patients with adult onset NE were reviewed with history, physical examination, urodynamic studies, questionnaires: Overactive bladder questionnaire short-form (OAB-qSF), Urogenital Distress Inventory (UDI-6), AUA symptom score (AUA-SS) and Patient Global Impression scale (PGIS). Results: Between 2004 and 2016, 45 NE patients (19 male, 26 female) were identified. Twenty-five patients (56%) had an associated diagnosis of neurogenic bladder (NGB). Five (11%) reported no other LUTS or associated conditions. Forty (89%) had at least one of the following contributing factors: sedative use, OAB (bothersome symptoms based on UDI-6), voiding dysfunction (also based on UDI-6 or AUA-SS), abnormal UDS finding, and/or confirmed obstructive sleep apnea (OSA). Overall, 20% had two contributing factors, and 31% each had three and four factors. Among all patients, 76% reported sedative use and of 36 patients with UDS, 75% had abnormal findings. Of the 41 questionnaire respondents, mean AUA-SS among men was 22.5 (range 8-35) and mean UDI-6 score among women was 9.3 (range 2-16). Mean PGI-S score was 3.1 (range 1-4) and mean Health Related Quality of Life (HRQL) subscale, as part of the OAB-q SF was 44 (range 22-78). Conclusions: Nocturnal enuresis is associated with multiple possible co-factors in all populations with majority reporting use of sedating medications. NE is associated with significant symptom bother and impacts greatly on QoL.

Original languageEnglish (US)
JournalLUTS: Lower Urinary Tract Symptoms
DOIs
StateAccepted/In press - 2017

Fingerprint

Nocturnal Enuresis
Quality of Life
Hypnotics and Sedatives
Overactive Urinary Bladder
Neurogenic Urinary Bladder
Urodynamics
Research Ethics Committees
Obstructive Sleep Apnea
Population
Physical Examination
Referral and Consultation
History
Surveys and Questionnaires
Pathology
Equipment and Supplies

Keywords

  • Adult
  • Nocturnal enuresis
  • Quality of life
  • Questionnaires

ASJC Scopus subject areas

  • Neurology
  • Urology

Cite this

Adult Onset Nocturnal Enuresis : Identifying Causes, Cofactors and Impact on Quality of Life. / Lee, Dominic; Dillon, Benjamin E.; Lemack, Gary E.

In: LUTS: Lower Urinary Tract Symptoms, 2017.

Research output: Contribution to journalArticle

@article{8b23bc77fe1c4b0b9767b24512ec57d0,
title = "Adult Onset Nocturnal Enuresis: Identifying Causes, Cofactors and Impact on Quality of Life",
abstract = "Objectives: The objectives of the present study were: (i) Evaluate common co-pathologies associated with, and potentially contributing to adult onset Nocturnal enuresis (NE) in a tertiary referral population; and (ii) quantify its impact on QoL with validated questionnaires. Methods: Following Institutional Review Board approval, patients with adult onset NE were reviewed with history, physical examination, urodynamic studies, questionnaires: Overactive bladder questionnaire short-form (OAB-qSF), Urogenital Distress Inventory (UDI-6), AUA symptom score (AUA-SS) and Patient Global Impression scale (PGIS). Results: Between 2004 and 2016, 45 NE patients (19 male, 26 female) were identified. Twenty-five patients (56{\%}) had an associated diagnosis of neurogenic bladder (NGB). Five (11{\%}) reported no other LUTS or associated conditions. Forty (89{\%}) had at least one of the following contributing factors: sedative use, OAB (bothersome symptoms based on UDI-6), voiding dysfunction (also based on UDI-6 or AUA-SS), abnormal UDS finding, and/or confirmed obstructive sleep apnea (OSA). Overall, 20{\%} had two contributing factors, and 31{\%} each had three and four factors. Among all patients, 76{\%} reported sedative use and of 36 patients with UDS, 75{\%} had abnormal findings. Of the 41 questionnaire respondents, mean AUA-SS among men was 22.5 (range 8-35) and mean UDI-6 score among women was 9.3 (range 2-16). Mean PGI-S score was 3.1 (range 1-4) and mean Health Related Quality of Life (HRQL) subscale, as part of the OAB-q SF was 44 (range 22-78). Conclusions: Nocturnal enuresis is associated with multiple possible co-factors in all populations with majority reporting use of sedating medications. NE is associated with significant symptom bother and impacts greatly on QoL.",
keywords = "Adult, Nocturnal enuresis, Quality of life, Questionnaires",
author = "Dominic Lee and Dillon, {Benjamin E.} and Lemack, {Gary E.}",
year = "2017",
doi = "10.1111/luts.12183",
language = "English (US)",
journal = "LUTS: Lower Urinary Tract Symptoms",
issn = "1757-5664",
publisher = "Wiley Blackwell",

}

TY - JOUR

T1 - Adult Onset Nocturnal Enuresis

T2 - Identifying Causes, Cofactors and Impact on Quality of Life

AU - Lee, Dominic

AU - Dillon, Benjamin E.

AU - Lemack, Gary E.

PY - 2017

Y1 - 2017

N2 - Objectives: The objectives of the present study were: (i) Evaluate common co-pathologies associated with, and potentially contributing to adult onset Nocturnal enuresis (NE) in a tertiary referral population; and (ii) quantify its impact on QoL with validated questionnaires. Methods: Following Institutional Review Board approval, patients with adult onset NE were reviewed with history, physical examination, urodynamic studies, questionnaires: Overactive bladder questionnaire short-form (OAB-qSF), Urogenital Distress Inventory (UDI-6), AUA symptom score (AUA-SS) and Patient Global Impression scale (PGIS). Results: Between 2004 and 2016, 45 NE patients (19 male, 26 female) were identified. Twenty-five patients (56%) had an associated diagnosis of neurogenic bladder (NGB). Five (11%) reported no other LUTS or associated conditions. Forty (89%) had at least one of the following contributing factors: sedative use, OAB (bothersome symptoms based on UDI-6), voiding dysfunction (also based on UDI-6 or AUA-SS), abnormal UDS finding, and/or confirmed obstructive sleep apnea (OSA). Overall, 20% had two contributing factors, and 31% each had three and four factors. Among all patients, 76% reported sedative use and of 36 patients with UDS, 75% had abnormal findings. Of the 41 questionnaire respondents, mean AUA-SS among men was 22.5 (range 8-35) and mean UDI-6 score among women was 9.3 (range 2-16). Mean PGI-S score was 3.1 (range 1-4) and mean Health Related Quality of Life (HRQL) subscale, as part of the OAB-q SF was 44 (range 22-78). Conclusions: Nocturnal enuresis is associated with multiple possible co-factors in all populations with majority reporting use of sedating medications. NE is associated with significant symptom bother and impacts greatly on QoL.

AB - Objectives: The objectives of the present study were: (i) Evaluate common co-pathologies associated with, and potentially contributing to adult onset Nocturnal enuresis (NE) in a tertiary referral population; and (ii) quantify its impact on QoL with validated questionnaires. Methods: Following Institutional Review Board approval, patients with adult onset NE were reviewed with history, physical examination, urodynamic studies, questionnaires: Overactive bladder questionnaire short-form (OAB-qSF), Urogenital Distress Inventory (UDI-6), AUA symptom score (AUA-SS) and Patient Global Impression scale (PGIS). Results: Between 2004 and 2016, 45 NE patients (19 male, 26 female) were identified. Twenty-five patients (56%) had an associated diagnosis of neurogenic bladder (NGB). Five (11%) reported no other LUTS or associated conditions. Forty (89%) had at least one of the following contributing factors: sedative use, OAB (bothersome symptoms based on UDI-6), voiding dysfunction (also based on UDI-6 or AUA-SS), abnormal UDS finding, and/or confirmed obstructive sleep apnea (OSA). Overall, 20% had two contributing factors, and 31% each had three and four factors. Among all patients, 76% reported sedative use and of 36 patients with UDS, 75% had abnormal findings. Of the 41 questionnaire respondents, mean AUA-SS among men was 22.5 (range 8-35) and mean UDI-6 score among women was 9.3 (range 2-16). Mean PGI-S score was 3.1 (range 1-4) and mean Health Related Quality of Life (HRQL) subscale, as part of the OAB-q SF was 44 (range 22-78). Conclusions: Nocturnal enuresis is associated with multiple possible co-factors in all populations with majority reporting use of sedating medications. NE is associated with significant symptom bother and impacts greatly on QoL.

KW - Adult

KW - Nocturnal enuresis

KW - Quality of life

KW - Questionnaires

UR - http://www.scopus.com/inward/record.url?scp=85021831045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021831045&partnerID=8YFLogxK

U2 - 10.1111/luts.12183

DO - 10.1111/luts.12183

M3 - Article

C2 - 28675645

AN - SCOPUS:85021831045

JO - LUTS: Lower Urinary Tract Symptoms

JF - LUTS: Lower Urinary Tract Symptoms

SN - 1757-5664

ER -